Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Completed 2

Sponsor Class

NETWORK 2

Study Type

Interventional 2

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 31Leukemia, Myeloid, Acute 16Burkitt Lymphoma 12Congenital Abnormalities 9Leukemia, Myeloid, Accelerated Phase 8Myeloproliferative Disorders 7Lymphoma, Mantle-Cell 7Leukemia, Lymphocytic, Chronic, B-Cell 7Multiple Myeloma 6Lymphoma, Non-Hodgkin 6Lymphoma, Large B-Cell, Diffuse 6Leukemia, Myelomonocytic, Chronic 6Hodgkin Disease 6Blast Crisis 6Myelodysplastic Syndromes 5Lymphoma, Follicular 5Lymphoma, B-Cell, Marginal Zone 5Leukemia, Myeloid, Chronic-Phase 5Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5Leukemia, Biphenotypic, Acute 5Hematologic Neoplasms 5Anemia, Refractory, with Excess of Blasts 5Primary Myelofibrosis 4Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4Lymphoma, Large-Cell, Immunoblastic 4Waldenstrom Macroglobulinemia 3Sezary Syndrome 3Mycosis Fungoides 3Lymphoma, T-Cell, Cutaneous 3Lymphoma, Large-Cell, Anaplastic 3

Interventions

Methotrexate 3merphos 2Dactinomycin 2Vitamin B Complex 1Pemetrexed 1Leucovorin 1Amifostine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Hydatidiform Mole × merphos × Clear all
NCT01535053 2022-08-12

Dactinomycin or Methotrexate in Treating Patients With Low-Risk Gestational Trophoblastic Neoplasia

GOG Foundation

Phase 3 Completed
57 enrolled 12 charts

Choriocarcinoma, Hydatidiform Mole

NCT00003702 2018-05-15

Methotrexate Compared With Dactinomycin in Treating Patients With Gestational Trophoblastic Neoplasia

GOG Foundation

Phase 3 Completed
240 enrolled 9 charts

Hydatidiform Mole

Data powered by HemOnc (CC BY 4.0) Colophon âš¡